Medications for obesity may improve fertility, but there are many unknowns when it comes to using them during pregnancy.

Although Super Bowl LX’s ad lineup had plenty of the usual beer, car and tech company pitches, drug and other healthcare companies also shelled out $8 million for a 30-second spot to send their ...

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...

For now, GLP-1 drugs remain a powerful tool for diabetes and obesity, with the potential to become much more. As research ...

Some GLP-1 patients are begging to stay on the drugs just a little bit longer, presenting an ethical dilemma for doctors.

Hims & Hers Health (NYSE:HIMS) introduced a low cost compounded semaglutide pill for weight loss, offering a needle free alternative to injectable drugs. Novo Nordisk responded with legal and ...

Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...

Boxes for the GLP-1 medications Wegovy and Zepbound on May 8. (JoNel Aleccia/AP) You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click ...

Novo Nordisk (CPSE:NOVO B) has taken legal action against telehealth platform Hims & Hers after it launched a compounded, non branded version of Wegovy, Novo Nordisk's weight loss pill. Following the ...

In clinical trials, weight loss with GLP-1 medications tends to follow a predictable curve: rapid early losses during drug initiation and dose increases, a gradual slowing and eventual plateau. A ...